Abstract
BackgroundOutcomes for high grade serous ovarian cancer (HGSOC) patients have remained dismal due to the inevitable development of chemotherapy resistance with recurrent disease.1 In order to better tailor treatment approaches...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have